Eric R. Kalkman

1.1k total citations
10 papers, 293 citations indexed

About

Eric R. Kalkman is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Eric R. Kalkman has authored 10 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Cell Biology. Recurrent topics in Eric R. Kalkman's work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Cellular transport and secretion (2 papers). Eric R. Kalkman is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Cellular transport and secretion (2 papers). Eric R. Kalkman collaborates with scholars based in United Kingdom, Netherlands and Hong Kong. Eric R. Kalkman's co-authors include Nick D. Read, Mari Valkonen, Markku Saloheimo, R. R. Duncan, Merja Penttilä, Alexander Schouten, J.A.L. van Kan, Míriam Osés-Ruiz, Mhairi Copland and Karen Dunn and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Controlled Release.

In The Last Decade

Eric R. Kalkman

10 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric R. Kalkman United Kingdom	8	157	136	79	31	24	10	293
Sarah Gold United States	6	293 1.9×	177 1.3×	66 0.8×	33 1.1×	11 0.5×	10	371
Ailisa Blum Australia	8	533 3.4×	157 1.2×	218 2.8×	18 0.6×	9 0.4×	10	705
Juliana Parsons Germany	13	356 2.3×	90 0.7×	13 0.2×	7 0.2×	34 1.4×	20	493
Evelyn Vollmeister Germany	11	309 2.0×	150 1.1×	113 1.4×	24 0.8×	21 0.9×	15	388
Madeleine Meusburger Germany	6	770 4.9×	62 0.5×	14 0.2×	14 0.5×	8 0.3×	6	832
Stephan Fath Germany	8	486 3.1×	34 0.3×	149 1.9×	25 0.8×	6 0.3×	8	565
Simon Léonard France	10	123 0.8×	114 0.8×	33 0.4×	4 0.1×	14 0.6×	18	314
Dibyendu Kumar United States	11	135 0.9×	179 1.3×	24 0.3×	8 0.3×	7 0.3×	21	329
Zhihao Guo China	10	222 1.4×	84 0.6×	41 0.5×	106 3.4×	4 0.2×	17	330
Katharina Mueller Germany	10	180 1.1×	616 4.5×	20 0.3×	27 0.9×	5 0.2×	20	765

Countries citing papers authored by Eric R. Kalkman

Since Specialization

Citations

This map shows the geographic impact of Eric R. Kalkman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric R. Kalkman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric R. Kalkman more than expected).

Fields of papers citing papers by Eric R. Kalkman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric R. Kalkman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric R. Kalkman. The network helps show where Eric R. Kalkman may publish in the future.

Co-authorship network of co-authors of Eric R. Kalkman

This figure shows the co-authorship network connecting the top 25 collaborators of Eric R. Kalkman. A scholar is included among the top collaborators of Eric R. Kalkman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric R. Kalkman. Eric R. Kalkman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kalkman, Eric R., Joe M. Jones, Daniel James, et al.. (2024). Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia. Science Translational Medicine. 16(751). eadi5336–eadi5336. 3 indexed citations

Kalkman, Eric R., Mary T. Scott, Karen Dunn, et al.. (2023). Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells. Nature Communications. 14(1). 4634–4634. 13 indexed citations

Kalkman, Eric R., Mary T. Scott, Karen Dunn, et al.. (2023). Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells. EMBO Reports. 24(10). e56279–e56279. 5 indexed citations

Scott, Mary T., Karen Dunn, Eric R. Kalkman, et al.. (2021). ULK1 inhibition promotes oxidative stress–induced differentiation and sensitizes leukemic stem cells to targeted therapy. Science Translational Medicine. 13(613). eabd5016–eabd5016. 35 indexed citations

Natto, Manal J., Fabian Hulpia, Eric R. Kalkman, et al.. (2021). Deazapurine Nucleoside Analogues for the Treatment of Trichomonas vaginalis. ACS Infectious Diseases. 7(6). 1752–1764. 14 indexed citations

Duffy, Margaret R., Alan L. Parker, Eric R. Kalkman, et al.. (2013). Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach. Journal of Controlled Release. 170(1). 132–140. 10 indexed citations

Kalkman, Eric R., et al.. (2010). Functional analysis and mode of action of phytotoxic Nep1-like proteins of Botrytis cinerea. Physiological and Molecular Plant Pathology. 74(5-6). 376–386. 61 indexed citations

Valkonen, Mari, Eric R. Kalkman, Markku Saloheimo, et al.. (2007). Spatially Segregated SNARE Protein Interactions in Living Fungal Cells. Journal of Biological Chemistry. 282(31). 22775–22785. 56 indexed citations

Read, Nick D. & Eric R. Kalkman. (2003). Does endocytosis occur in fungal hyphae?. Fungal Genetics and Biology. 39(3). 199–203. 55 indexed citations

10.

Kalkman, Eric R.. (1984). Analysis of the C-banded karyotype of Allium cepa L. Standard system of nomenclature and polymorphism. Genetica. 65(2). 141–148. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact